Personalized vaccination against ovarian cancer: what are the possibilities?
作者信息
Tanyi Janos L, George Erin
机构信息
a Department of Obstetrics and Gynecology , University of Pennsylvania Perelman School of Medicine , Philadelphia , USA.
出版信息
Expert Rev Vaccines. 2018 Nov;17(11):955-958. doi: 10.1080/14760584.2018.1541743. Epub 2018 Nov 7.
Abstract
摘要
相似文献
1
Personalized vaccination against ovarian cancer: what are the possibilities?针对卵巢癌的个性化疫苗接种：有哪些可能性？
Expert Rev Vaccines. 2018 Nov;17(11):955-958. doi: 10.1080/14760584.2018.1541743. Epub 2018 Nov 7.
2
Personalized neoantigen vaccines: A new approach to cancer immunotherapy.个体化新抗原疫苗：癌症免疫治疗的新途径。
Bioorg Med Chem. 2018 Jun 1;26(10):2842-2849. doi: 10.1016/j.bmc.2017.10.021. Epub 2017 Oct 19.
3
Cancer neoantigen: Boosting immunotherapy.癌症新生抗原：增强免疫疗法。
Biomed Pharmacother. 2020 Nov;131:110640. doi: 10.1016/j.biopha.2020.110640. Epub 2020 Aug 21.
4
Ovarian cancer vaccine candidate DPX-Survivac: positive interim results from phase 1.卵巢癌候选疫苗DPX-Survivac：1期试验的阳性中期结果。
Hum Vaccin Immunother. 2012 Dec 1;8(12):1743.
5
Vaccine-based clinical trials in ovarian cancer.卵巢癌的疫苗临床试验。
Expert Rev Vaccines. 2011 Jun;10(6):775-84. doi: 10.1586/erv.11.42.
6
Personalized cancer neoantigen vaccines come of age.个体化癌症新生抗原疫苗崭露头角。
Theranostics. 2018 Jul 30;8(15):4238-4246. doi: 10.7150/thno.24387. eCollection 2018.
7
Prospects for a personalized peptide vaccine against lung cancer.针对肺癌的个体化肽疫苗的前景。
Expert Rev Vaccines. 2019 Jul;18(7):703-709. doi: 10.1080/14760584.2019.1635461. Epub 2019 Jun 28.
8
Prospects and challenges for immunotherapy of ovarian cancer--what can we learn from the tumor microenvironment?卵巢癌免疫治疗的前景与挑战——肿瘤微环境能给我们带来什么启示？
Int Rev Immunol. 2011 Apr-Jun;30(2-3):67-70. doi: 10.3109/08830185.2011.571731.
9
Personalized peptide vaccines and their relation to other therapies in urological cancer.个性化肽疫苗及其与泌尿癌症其他疗法的关系。
Nat Rev Urol. 2017 Aug;14(8):501-510. doi: 10.1038/nrurol.2017.77. Epub 2017 May 31.
10
Understanding dendritic cell immunotherapy in ovarian cancer.了解卵巢癌中的树突状细胞免疫疗法。
Expert Rev Anticancer Ther. 2016 Jun;16(6):643-52. doi: 10.1080/14737140.2016.1178576. Epub 2016 May 13.
引用本文的文献
1
Advances in Dendritic-Cell-Based Vaccines against Respiratory Fungal Infections.基于树突状细胞的抗呼吸道真菌感染疫苗的研究进展
Vaccines (Basel). 2024 Aug 28;12(9):981. doi: 10.3390/vaccines12090981.
2
Tumor targeting peptide TMTP1 modified Antigen capture Nano-vaccine combined with chemotherapy and PD-L1 blockade effectively inhibits growth of ovarian cancer.肿瘤靶向肽 TMTP1 修饰的抗原捕获纳米疫苗联合化疗和 PD-L1 阻断可有效抑制卵巢癌的生长。
J Nanobiotechnology. 2024 Aug 13;22(1):483. doi: 10.1186/s12951-024-02744-6.
3
Ubiquitin D promotes the progression of rheumatoid arthritis via activation of the p38 MAPK pathway.泛素 D 通过激活 p38 MAPK 通路促进类风湿性关节炎的进展。
Mol Med Rep. 2023 Feb;27(2). doi: 10.3892/mmr.2023.12940. Epub 2023 Jan 20.
4
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant.卵巢癌的免疫治疗：辅助、联合和新辅助治疗。
Front Immunol. 2020 Oct 6;11:577869. doi: 10.3389/fimmu.2020.577869. eCollection 2020.
5
Advanced cell therapeutics are changing the clinical landscape: will mesenchymal stromal cells be a part of it?先进的细胞治疗正在改变临床格局：间充质基质细胞会成为其中的一部分吗？
BMC Med. 2019 Mar 5;17(1):53. doi: 10.1186/s12916-019-1289-6.
本文引用的文献
1
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer.个体化癌症疫苗能有效调动卵巢癌抗肿瘤 T 细胞免疫。
Sci Transl Med. 2018 Apr 11;10(436). doi: 10.1126/scitranslmed.aao5931.
2
Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials.基于树突状细胞的抗肿瘤疫苗：从动物肿瘤模型实验到临床试验
Acta Naturae. 2017 Jul-Sep;9(3):27-38.
3
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.个体化 RNA 突变疫苗可动员针对癌症的多特异性治疗性免疫。
Nature. 2017 Jul 13;547(7662):222-226. doi: 10.1038/nature23003. Epub 2017 Jul 5.
4
Cancer-testis antigen expression is shared between epithelial ovarian cancer tumors.上皮性卵巢癌肿瘤之间存在癌-睾丸抗原表达。
Gynecol Oncol. 2017 Jun;145(3):413-419. doi: 10.1016/j.ygyno.2017.03.512. Epub 2017 Apr 6.
5
Personalized cancer vaccines: Targeting the cancer mutanome.个性化癌症疫苗：靶向癌症突变组。
Vaccine. 2017 Feb 15;35(7):1094-1100. doi: 10.1016/j.vaccine.2016.05.073. Epub 2016 Jul 20.
6
Next generation prophylactic human papillomavirus vaccines.下一代预防性人乳头瘤病毒疫苗。
Lancet Oncol. 2015 May;16(5):e217-25. doi: 10.1016/S1470-2045(14)71179-9.
7
Neoantigens in cancer immunotherapy.肿瘤免疫治疗中的新生抗原
Science. 2015 Apr 3;348(6230):69-74. doi: 10.1126/science.aaa4971.
8
Therapeutic vaccines for cancer: an overview of clinical trials.癌症治疗性疫苗：临床试验概述。
Nat Rev Clin Oncol. 2014 Sep;11(9):509-24. doi: 10.1038/nrclinonc.2014.111. Epub 2014 Jul 8.
9
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors.肿瘤内皮细胞 FasL 建立了选择性免疫屏障，促进肿瘤中的耐受。
Nat Med. 2014 Jun;20(6):607-15. doi: 10.1038/nm.3541. Epub 2014 May 4.
10
Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.NY-ESO-1 疫苗治疗在人类卵巢癌中的表观遗传增强作用。
Cancer Immunol Res. 2014 Jan;2(1):37-49. doi: 10.1158/2326-6066.CIR-13-0126.
Zotero 插件